UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1645) 1645
life sciences & biomedicine (1537) 1537
humans (1170) 1170
animals (1057) 1057
biochemistry & molecular biology (983) 983
proprotein convertases (687) 687
mice (493) 493
amino acid sequence (492) 492
molecular sequence data (458) 458
male (361) 361
serine endopeptidases - metabolism (356) 356
proprotein convertase 9 (344) 344
cell biology (322) 322
proprotein convertases - metabolism (321) 321
serine endopeptidases - genetics (318) 318
female (286) 286
cell line (250) 250
cholesterol (235) 235
subtilisins - metabolism (233) 233
protein processing, post-translational (216) 216
proprotein convertases - genetics (211) 211
mutation (207) 207
furin (195) 195
lipids (195) 195
base sequence (179) 179
rats (178) 178
protein precursors - metabolism (174) 174
proteins (173) 173
endocrinology & metabolism (172) 172
saccharomyces cerevisiae proteins (158) 158
research (156) 156
receptors, ldl - metabolism (155) 155
biophysics (153) 153
proprotein convertase 2 (151) 151
cholesterol, ldl - blood (142) 142
gene expression (133) 133
low density lipoproteins (127) 127
enzymes (126) 126
pcsk9 (126) 126
research article (125) 125
subtilisins - genetics (125) 125
biochemistry (117) 117
analysis (115) 115
adult (113) 113
cardiovascular system & cardiology (110) 110
binding sites (109) 109
middle aged (108) 108
hypercholesterolemia (104) 104
substrate specificity (104) 104
aspartic acid endopeptidases - metabolism (102) 102
proprotein convertase (102) 102
atherosclerosis (101) 101
cricetinae (97) 97
cardiovascular disease (96) 96
cells, cultured (95) 95
kinetics (94) 94
blotting, western (93) 93
transfection (90) 90
lipoproteins (88) 88
aged (87) 87
proprotein convertases - antagonists & inhibitors (87) 87
mice, knockout (86) 86
cho cells (84) 84
cell line, tumor (82) 82
furin - metabolism (79) 79
aspartic acid endopeptidases - genetics (77) 77
genetic aspects (77) 77
physiological aspects (76) 76
receptors, ldl - genetics (76) 76
cloning, molecular (75) 75
genetics & heredity (72) 72
endocrine system (68) 68
rna, messenger - metabolism (67) 67
proteolysis (66) 66
biotechnology & applied microbiology (65) 65
kexin (65) 65
science & technology - other topics (65) 65
abridged index medicus (64) 64
multidisciplinary sciences (64) 64
recombinant proteins - metabolism (64) 64
pharmacology & pharmacy (63) 63
protein binding (63) 63
protein structure, tertiary (63) 63
biology (62) 62
cholesterol, ldl - metabolism (60) 60
mice, inbred c57bl (60) 60
cardiovascular diseases (58) 58
genes (58) 58
subtilisin (55) 55
amino acids (54) 54
animal structures (54) 54
liver - metabolism (53) 53
cardiac & cardiovascular systems (52) 52
hep g2 cells (51) 51
peptides (50) 50
cholesterol - blood (48) 48
endopeptidases - metabolism (48) 48
proprotein convertase 9 - metabolism (48) 48
cholesterol - metabolism (47) 47
enzyme activation (47) 47
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1913) 1913
Japanese (19) 19
Chinese (2) 2
German (2) 2
Russian (2) 2
Spanish (2) 2
French (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2011, Methods in molecular biology, ISBN 1617792039, Volume 768., xi, 367
Book
2006, ISBN 9781402047930, x, 157
Convertases are widely expressed activating enzymes involved in various physiological and pathological processes... 
Treatment | Enzyme inhibitors | Genetic aspects | Carcinogenesis | Molecular aspects | Therapeutic use | Cancer
Book
Circulation (New York, N.Y.), ISSN 0009-7322, 10/2015, Volume 132, Issue 17, pp. 1648 - 1666
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in the regulation of cholesterol homeostasis... 
Antibodies, monoclonal | Clinical trial | PCSK9 protein, human | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Proprotein Convertases - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Serine Endopeptidases - physiology | Antibodies, Monoclonal - therapeutic use | Intestines - metabolism | Structure-Activity Relationship | Cardiovascular Diseases - enzymology | Molecular Targeted Therapy | Cardiovascular Diseases - genetics | Proprotein Convertases - genetics | Incidence | Brain - metabolism | RNA Interference | Oligonucleotides, Antisense - therapeutic use | Serine Endopeptidases - genetics | Cardiovascular Diseases - epidemiology | Protein Structure, Tertiary | Genetic Predisposition to Disease | Antibodies, Monoclonal, Humanized - therapeutic use | Serine Endopeptidases - deficiency | Liver - metabolism | Receptors, LDL - metabolism | Serine Endopeptidases - chemistry | Clinical Trials as Topic | Proprotein Convertases - chemistry | Proprotein Convertases - deficiency | Proprotein Convertases - physiology | Animals | RNA, Small Interfering - therapeutic use | Adipocytes - metabolism | Cholesterol, LDL - metabolism | Hyperlipoproteinemias - genetics | Mice | Peptide Fragments - therapeutic use | Mutation | Proprotein Convertase 9 | Monoclonal antibodies | Clinical trials | Usage | Care and treatment | Dosage and administration | Cardiovascular diseases | Index Medicus | Abridged Index Medicus
Journal Article
Circulation research, ISSN 0009-7330, 03/2014, Volume 114, Issue 6, pp. 1022 - 1036
Since the discovery of proprotein convertase subtilisin kexin 9 (PCSK9) in 2003, this PC has attracted a lot of attention from the scientific community and pharmaceutical companies... 
hyperlipoproteinemia type II | clinical trials | LDL cholesterol | phase III as topic | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Proprotein Convertases - antagonists & inhibitors | Hepatitis C - metabolism | Vertebrates - genetics | Humans | Serine Endopeptidases - physiology | Male | Risk | Hepatocytes - metabolism | Molecular Targeted Therapy | Cardiovascular Diseases - genetics | Proprotein Convertases - genetics | Endosomes - metabolism | Clinical Trials, Phase III as Topic | Lysosomes - metabolism | Insulin Resistance - physiology | Serine Endopeptidases - genetics | Cardiovascular Diseases - blood | Adult | Cholesterol, LDL - blood | Female | Lipoproteins, LDL - metabolism | Hyperlipoproteinemia Type II - drug therapy | Chromosomes, Human, Pair 1 - genetics | Child | Disease Models, Animal | Genetic Predisposition to Disease | Serine Endopeptidases - deficiency | Cardiovascular Diseases - metabolism | Rodentia | Low Density Lipoprotein Receptor-Related Protein-1 - metabolism | Receptors, LDL - metabolism | Serine Endopeptidases - chemistry | Proprotein Convertases - chemistry | Organ Specificity | Proprotein Convertases - deficiency | Gene Expression Regulation, Enzymologic | Hyperlipoproteinemia Type II - metabolism | Pregnancy | Proprotein Convertases - physiology | Animals | Diet | Protein Processing, Post-Translational | Mutation | Aging - metabolism | Hyperlipoproteinemia Type II - genetics | Proprotein Convertase 9 | Index Medicus
Journal Article
2013, Colloquium series on protein activation and cancer, ISBN 1615045368, 88
Proprotein convertases (PCs) are a family of proteases including PC1, PC2, Furin, PC4, PACE4, PC5, and PC7... 
Life Sciences | Molecular Biology | SCIENCE | Protein precursors
eBook
2014, Colloquium digital library of life sciences;Colloquium series on protein activation and cancer, ISBN 1615046100, Volume 6, 68
The vascular endothelial growth factor (VEGF) family members that include VEGF-A, -B, -C, -D,and placental growth factor (PlGF), display distinct binding... 
Medical | Biochemistry | Proprotein convertases | Vascular endothelial growth factors
eBook
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 03/2011, Volume 286, Issue 11, pp. 9321 - 9337
Journal Article